C. Hruza

DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer.

P. Sevelda, S. Leodolter, M. Medl, 1995, Gynecologic oncology.

Clinical therapy and HER-2 oncogene amplification in breast cancer: Chemo- vs radiotherapy

J. Spona, G. Locker, H. Helmer, 1994, Journal of Steroid Biochemistry and Molecular Biology.

First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer.

P. Sevelda, S. Leodolter, H. Salzer, 1993, British Journal of Cancer.

HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples.

S. Leodolter, M. Medl, K. Czerwenka, 1993, European journal of cancer.